implanet
-
Spine
IMPLANET Announces the European Launch of the MIS Range, a Minimally Invasive Pedicle Screw System
First innovation resulting from the partnership with Sanyou MedicalFirst orders received in June 2023 BORDEAUX, France & BOSTON, June 22,…
Read More » -
Spine
IMPLANET Receives FDA Clearance for Its Squale™ Anterior Cervical Cage Range
April 11, 2023 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans)…
Read More » -
Financial
IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%
Record unit sales of JAZZ® solutions (+31%)Export sales momentum recorded in the first 3 quarters of 2022 January 25, 2023 BORDEAUX,…
Read More » -
Spine
IMPLANET Signs an Exclusive Distribution Contract for SMTP Technology Co.’s Ultrasonic Surgical Scalpel in France
SMTP Technology Co., a Sanyou Medical subsidiary, is a Chinese company specialized in manufacturing and marketing ultrasonic medical equipmentExclusive distribution…
Read More » -
Spine
IMPLANET Signs a Distribution Agreement With Sanyou Medical in China and a Technological Partnership for the Development of a New Product Range
Finalization of the distribution agreement in China for Implanet’s JAZZ® platformTechnological know-how synergies for the development of a brand-new European hybrid…
Read More » -
Spine
Implanet Announces a Commercial, Technological and Financial Partnership With Sanyou Medical, a Chinese Manufacturer of Medical Devices for Spine Surgery
Commercial partnership: Agreement to distribute Implanet’s JAZZ® platform in China, the world’s largest market (by volume) for spine surgeryTechnological partnership: Joint…
Read More » -
Spine
IMPLANET Announces the First Surgical Operations in the United States with the ORIGIN Cervical Plate
First synergies with OSD products in the United StatesStrengthening of Implanet’s presence in the U.S. Spine market February 22, 2022…
Read More » -
Spine
IMPLANET Announces the First Surgical Procedures in the United States with JAZZ™ PF
JAZZ™ PF: a simple, innovative and proprietary addition to the JAZZ® rangeAddressable annual market of almost $350 million in the United…
Read More » -
Financial
IMPLANET Announces 2021 Revenue Growth of 58%, Under IFRS
Total revenue of €7.7 million, +29% including the divested MADISONTM activitySuccessful strategic repositioning: strengthening of the Spine business (+62% in 2021)…
Read More » -
Recon
Implanet Announces the Planned Divestment of Its Knee Prosthesis to Focus on Its Spine Business
Initiation of exclusive negotiations with the Menix Group’s SERF companyStrategic refocus to become a benchmark player in Spine surgery September…
Read More » -
Financial
Implanet Reports Q1 2021 Revenue of €1.7 Million, Driven by the Dramatic Growth of Its Spine Activity
April 20, 2021 Global revenue growth: +7%, driven by +13% increase in direct salesGrowth in JAZZ® Spine activity: +41% A webinar…
Read More » -
Financial
Implanet Finalizes the Agreement to Acquire OSD, a Manufacturer of Implants for Spine Surgery, to Create a New Benchmark Player
Acquisition of 100% of OSD’s share capital1Acquisition subject to the approval of Implanet’s shareholders at the Shareholders’ Meeting of May…
Read More » -
Financial
Implanet confirms offer to acquire a majority stake in Orthopaedic & Spine Development
Orthopaedic & Spine Development (“OSD”) is a manufacturer of implants for spine surgeryAcquisition of a majority interest will lead to…
Read More » -
Financial
Implanet announces 2020 revenue of €6 million
Annual revenue impacted by the health crisis associated with the pandemicFourth quarter JAZZ® sales up 9% compared with the fourth quarter…
Read More » -
Spine
Implanet Signs Distribution Agreement for Its JAZZ® Platform Products in Mexico
November 4, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings…
Read More »